Type 2 Diabetes May Be Prevented With a Combination of Avandia and Metformin

According to a new report published in the Lancet, taking a low dose of GlaxoSmithKline’s diabetes drug Avandia (rosiglitazone) combined with metformin was highly effective in prevention of type 2 diabetes in patients with impaired glucose tolerance, with little effect on the clinically relevant adverse events of these two drugs.
The study included 207 patients with impaired glucose tolerance who were randomly assigned to receive combination rosiglitazone (2 mg) and metformin (500 mg) twice daily or matching placebo for a median of 3·9 years. The researchers found significantly fewer individuals in the active treatment group (14%) developed type 2 diabetes compared with the placebo group (39%).

The research was funded by GlaxoSmithKline.

ASweetLife Team

Metformin Recalls: What You Need to Know Over the past 6 weeks multiple companies have issued recalls for extended-release metformin, the oral diabetes medicine used to help control blood sugar. The recalls were caused by high levels…
Should Metformin Be Used to Treat Prediabetes? About one third of all American adults have prediabetes, an astonishing 88 million Americans, according to the criteria developed by the American Diabetes Association (ADA). The CDC further estimates that…
What Poop May Tell Us about Type 1 Diabetes It is now clear that over recent generations there has been a distinct rise in Type 1 diabetes. You may never have considered that scientists on the vanguard of this…
Teplizumab May Prevent Type 1 Diabetes Progression There’s been more good news for Teplizumab, the promising drug that may delay the onset of Type 1 diabetes and even potentially prevent it from developing. In 2019 we reported…
COVID-19 May Be Triggering Type 1 Diabetes in Children A new study out of the UK suggests that diagnoses of Type 1 diabetes may have nearly doubled during the COVID-19 pandemic. The study, published in the journal Diabetes Care…